Announced
Completed
Synopsis
CPE, China Life Investment Management and Fortune Capital led a $126m Series C funding round in SiBionics, a medtech firm, with participation from China Life, Qianhai FOF, C&D, JD Invesment, Jingming Capital, Lucion, Source Code Capital, Cedarlake Capital and Riverhead Capital.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.